NCT00171431View on ClinicalTrials.gov

The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)

PHASE3TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Constipation PredominantIrritable Bowel Syndrome (IBS-C)
Interventions
DRUG

Tegaserod

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY